180 related articles for article (PubMed ID: 23719783)
1. Cell transplantation therapy for diabetes mellitus: endocrine pancreas and adipocyte.
Fujikura J; Hosoda K; Nakao K
Endocr J; 2013; 60(6):697-708. PubMed ID: 23719783
[TBL] [Abstract][Full Text] [Related]
2. Development of the endocrine pancreas and novel strategies for β-cell mass restoration and diabetes therapy.
Márquez-Aguirre AL; Canales-Aguirre AA; Padilla-Camberos E; Esquivel-Solis H; Díaz-Martínez NE
Braz J Med Biol Res; 2015 Sep; 48(9):765-76. PubMed ID: 26176316
[TBL] [Abstract][Full Text] [Related]
3. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
Dadheech N; James Shapiro AM
Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
[TBL] [Abstract][Full Text] [Related]
4. Generating β cells from stem cells-the story so far.
Hebrok M
Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007674. PubMed ID: 22675664
[TBL] [Abstract][Full Text] [Related]
5. Generation of insulin-producing cells from pluripotent stem cells: from the selection of cell sources to the optimization of protocols.
Liew CG
Rev Diabet Stud; 2010; 7(2):82-92. PubMed ID: 21060967
[TBL] [Abstract][Full Text] [Related]
6. From substitution of insulin to replacement of insulin producing cells: New therapeutic opportunities from research on pancreas development and stem cell differentiation.
Zulewski H
Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):815-20. PubMed ID: 26696511
[No Abstract] [Full Text] [Related]
7. Diabetes mellitus: a potential target for stem cell therapy.
Burns CJ; Persaud SJ; Jones PM
Curr Stem Cell Res Ther; 2006 May; 1(2):255-66. PubMed ID: 18220871
[TBL] [Abstract][Full Text] [Related]
8. Generating insulin-producing cells for diabetic therapy: existing strategies and new development.
Shen J; Cheng Y; Han Q; Mu Y; Han W
Ageing Res Rev; 2013 Mar; 12(2):469-78. PubMed ID: 23318683
[TBL] [Abstract][Full Text] [Related]
9. [Cellular therapy of diabetes: focus on the latest developments].
Lysy PA
Med Sci (Paris); 2016 Apr; 32(4):401-7. PubMed ID: 27137698
[TBL] [Abstract][Full Text] [Related]
10. Development of human insulin-producing cells for cell therapy of diabetes.
Russ HA; Efrat S
Pediatr Endocrinol Rev; 2011 Dec; 9(2):590-7. PubMed ID: 22397143
[TBL] [Abstract][Full Text] [Related]
11. Cell-based treatments for diabetes.
Jones PM; Courtney ML; Burns CJ; Persaud SJ
Drug Discov Today; 2008 Oct; 13(19-20):888-93. PubMed ID: 18652911
[TBL] [Abstract][Full Text] [Related]
12. Human pluripotent stem cell based islet models for diabetes research.
Balboa D; Otonkoski T
Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):899-909. PubMed ID: 26696518
[TBL] [Abstract][Full Text] [Related]
13. Regenerative medicine for insulin deficiency: creation of pancreatic islets and bioartificial pancreas.
Sumi S
J Hepatobiliary Pancreat Sci; 2011 Jan; 18(1):6-12. PubMed ID: 20589399
[TBL] [Abstract][Full Text] [Related]
14. Stem cells and the endocrine pancreas.
Wu Y; Persaud SJ; Jones PM
Br Med Bull; 2011; 100():123-35. PubMed ID: 21642368
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
16. The Human Endocrine Pancreas: New Insights on Replacement and Regeneration.
Domínguez-Bendala J; Lanzoni G; Klein D; Álvarez-Cubela S; Pastori RL
Trends Endocrinol Metab; 2016 Mar; 27(3):153-162. PubMed ID: 26774512
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells in the treatment of type 1 diabetes mellitus.
Katuchova J; Harvanova D; Spakova T; Kalanin R; Farkas D; Durny P; Rosocha J; Radonak J; Petrovic D; Siniscalco D; Qi M; Novak M; Kruzliak P
Endocr Pathol; 2015 May; 26(2):95-103. PubMed ID: 25762503
[TBL] [Abstract][Full Text] [Related]
18. Pluripotent stem cells, a potential source of beta-cells for diabetes therapy.
Hansson M; Madsen OD
Curr Opin Investig Drugs; 2010 Apr; 11(4):417-25. PubMed ID: 20336589
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming into pancreatic endocrine cells based on developmental cues.
Kordowich S; Mansouri A; Collombat P
Mol Cell Endocrinol; 2010 Jul; 323(1):62-9. PubMed ID: 20025937
[TBL] [Abstract][Full Text] [Related]
20. Normal relationship of beta- and non-beta-cells not needed for successful islet transplantation.
King AJ; Fernandes JR; Hollister-Lock J; Nienaber CE; Bonner-Weir S; Weir GC
Diabetes; 2007 Sep; 56(9):2312-8. PubMed ID: 17563059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
